TelAve News/10454205

Zebra BI Recognized by CIOReview for Data Visualization

The Excel Add-On product combines incredible capabilities in a cost efficient package to create visualizations for variance analysis, with smart reporting and charts features.

NEW YORK - March 3, 2016 - TelAve -- Zebra BI, an Excel add-in for data visualization and quick reporting, was recognized in January as one of CIOReview's 20 Most Promising Providers of 2016.

Zebra BI was selected after being evaluated across more than a dozen quantitative and qualitative elements. CIOReview experts considered company experience, industry recognition, technical certifications, market presence, and positive client reviews.

"Zebra BI continued to break new ground within the past year benefiting its customers around the globe, and we're excited to have them featured on our top companies list," said Jeevan George, CIOReview Managing Editor.

More on TelAve News
He added, "Zebra BI has been on our radar for some time now for stirring a revolution in the data visualization technologies, and we are happy to showcase them this year due to their continuing excellence in delivering top-notch technology-driven solutions."

Since its launch 19 months ago, Zebra BI has been adopted by large, medium, and small companies across the globe, including Coca-Cola, Roche, Sanofi, Heineken, Carlsberg, Volvo Bus, Konica Minolta, Saudi Airlines, US Gas & Electric, Telekom Srbije, Hemofarm, and others. In 2015, Zebra BI software earned the certificate for excellence issued by the IBCS Association (International Business Communication Standards).

About Zebra BI

Zebra BI is an Excel add-in that helps create best-practice business reports, dashboards, and presentations in just a few clicks. Zebra BI makes financial reports crystal clear to all levels of management in real working conditions where reader's available attention is limited. For more information, visit: https://zebra.bi/

Contact
Alex Romanovich
***@zebra.bi


Source: Zebra BI
Tags: Finance

Show All News |

0 Comments